write information about covid sheild vaccination?
Answers
Answer:
A COVID‐19 vaccine is a vaccine intended to provide acquired immunity against severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2), the virus causing coronavirus disease 2019 (COVID‐19)
Explanation:
In ongoing clinical trials, the Covishield vaccine has been shown to prevent COVID-19 disease following 2 doses given between 4 and 12 weeks apart. The duration of protection against COVID-19 disease is currently unknown. You may get protective immune response 4 weeks after the second dose of Covishield vaccine
Explanation:
India's Covaxin, the homegrown government-backed vaccine, has an efficacy rate of 81%, preliminary data from its phase 3 trial shows.
India's Covaxin, the homegrown government-backed vaccine, has an efficacy rate of 81%, preliminary data from its phase 3 trial shows.India's regulators gave the vaccine an emergency approval in January while the third phase of the trial was still under way, sparking scepticism and questions from experts.
India's Covaxin, the homegrown government-backed vaccine, has an efficacy rate of 81%, preliminary data from its phase 3 trial shows.India's regulators gave the vaccine an emergency approval in January while the third phase of the trial was still under way, sparking scepticism and questions from experts.Bharat Biotech, the vaccine's manufacturer, said the latest findings were "an important milestone in vaccine discovery, for science and our fight against coronavirus".